Success Metrics

Clinical Success Rate
88.7%

Based on 63 completed trials

Completion Rate
89%(63/71)
Active Trials
23(18%)
Results Posted
21%(13 trials)
Terminated
8(6%)

Phase Distribution

Ph phase_1
4
3%
Ph not_applicable
73
58%
Ph phase_2
27
22%
Ph phase_3
3
2%

Phase Distribution

4

Early Stage

27

Mid Stage

3

Late Stage

Phase Distribution107 total trials
Phase 1Safety & dosage
4(3.7%)
Phase 2Efficacy & side effects
27(25.2%)
Phase 3Large-scale testing
3(2.8%)
N/ANon-phased studies
73(68.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.1%

63 of 74 finished

Non-Completion Rate

14.9%

11 ended early

Currently Active

23

trials recruiting

Total Trials

125

all time

Status Distribution
Active(31)
Completed(63)
Terminated(11)
Other(20)

Detailed Status

Completed63
unknown20
Recruiting18
Terminated8
Not yet recruiting6
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
125
Active
23
Success Rate
88.7%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (3.7%)
Phase 227 (25.2%)
Phase 33 (2.8%)
N/A73 (68.2%)

Trials by Status

withdrawn32%
completed6350%
active_not_recruiting54%
enrolling_by_invitation22%
not_yet_recruiting65%
unknown2016%
terminated86%
recruiting1814%

Recent Activity

Clinical Trials (125)

Showing 20 of 125 trialsScroll for more
NCT06189027Phase 3

Epigenetics and MDMA-Assisted Psychotherapy for PTSD

Completed
NCT07507370Not Applicable

CARED : A Novel Rapid Treatment Paradigm for Depression

Recruiting
NCT03376269Not Applicable

HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

Completed
NCT07336238Phase 2

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Recruiting
NCT06538285Phase 2

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Active Not Recruiting
NCT06004414Not Applicable

SilverCloud as a School-Based Intervention for Vulnerable Youth

Recruiting
NCT07200531Not Applicable

Does Psychotherapy Change the Gut Microbiome in Women of Child-bearing Age?

Recruiting
NCT06827054Phase 2

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Not Yet Recruiting
NCT06253403

Female Sexual Dysfunction and Anorexia Nervosa

Completed
NCT07432646

"Finding Solid Ground" in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Treatment Settings: A 1-year Follow-up Pilot Study

Completed
NCT06042751Not Applicable

Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom

Active Not Recruiting
NCT04950608Phase 2

Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care

Completed
NCT06206265Phase 2

Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)

Active Not Recruiting
NCT07250893Not Applicable

Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression

Recruiting
NCT05398484Phase 2

Psilocybin Therapy in Advanced Cancer

Recruiting
NCT07253935Not Applicable

Impact of Therapeutic Exercise Integrated With Psychotherapy and Education in Patients With Depression

Not Yet Recruiting
NCT07011758Phase 2

Dynamic Treatment Regimes for Opioid Use Disorder

Not Yet Recruiting
NCT06051721Phase 2

A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)

Active Not Recruiting
NCT07180290Not Applicable

Evaluation of the ChronoS Therapy on the Severity of Sleep Disturbances Among Patients With Mood Disorders: A Within-subjects Study

Completed
NCT06091306

Qualitative Evaluation of Change Processes in Multifamily Therapy for Adolescents With Anorexia Nervosa

Recruiting

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
125